Leef Brands (LEEEF) Net Income (2025 - 2026)
Leef Brands (LEEEF) reported Net Income of -$426253.0 for Q1 2026, down 260.38% on a YoY basis from $265776.0 in Q1 2025, and down 260.38% sequentially from $265776.0 in Q1 2025.
Leef Brands (LEEEF) Net Income (2025 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 2 years of Net Income data on file, last reported at -$426253.0 in Q1 2026.
- For the quarter ending Q1 2026, Net Income fell 260.38% year-over-year to -$426253.0; the trailing twelve-month figure through Mar 2026 stood at -$160477.0 (changed N/A YoY), and the FY2025 full-year result was -$17.6 million, up 28.77% from the prior year.
- Net Income fell to -$426253.0 in Q1 2026, from $265776.0 in the prior quarter.
- In the past five years, Net Income ranged from a high of $265776.0 in Q1 2025 to a low of -$426253.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn | -426,253.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -426,253.00 |
| Mar 31, 2025 | 265,776.00 |